Target intelligence / Profile preview

Host cell surface receptors for viral vector entry

Molecular classification
Receptor, Glycoprotein, Proteoglycan, Cell adhesion molecule
01

Overview

Host cell surface receptors for viral vector entry represent a diverse class of membrane-bound molecules, including proteins, glycoproteins, and proteoglycans, that facilitate the attachment and internalization of therapeutic viral vectors (Bulcha et al., 2021). These receptors are the primary determinants of viral tropism, defining which tissues and cell types can be effectively transduced by specific vectors such as Adeno-associated virus (AAV), Lentivirus, or Adenovirus. For instance, the Adeno-associated virus receptor (AAVR, encoded by KIAA0319L) is an essential host factor for the entry of multiple AAV serotypes, while the Coxsackievirus and adenovirus receptor (CAR) is the primary attachment site for many adenoviral vectors (Pillay et al., 2016; Bergelson et al., 1997). In many cases, vectors are pseudotyped with foreign glycoproteins, such as the Vesicular Stomatitis Virus G protein (VSV-G), to utilize ubiquitous receptors like the Low-density lipoprotein receptor (LDLR) for broader cell entry (Finkelshtein et al., 2013). The density and availability of these receptors on target cells are critical for the success of gene therapies, and their interaction with vectors can be hindered by pre-existing neutralizing antibodies or off-target sequestration in the liver (Summerford & Samulski, 1998). Consequently, these receptors are central to the design of targeted delivery systems and the assessment of patient eligibility for viral-mediated genetic interventions.

Other names
Viral entry receptorsViral attachment factorsHost cell receptorsTransduction receptors
02

Mechanism of action

Facilitation of viral attachment, membrane fusion, and receptor-mediated endocytosis for the delivery of genetic payloads.

03

Biological functions

Viral entryEndocytosisCell-virus interactionCell adhesion
04

Disease associations

InfectionGenetic diseaseCancer
05

Safety considerations

Off-target transductionImmunogenicityNeutralizing antibodiesLimited tissue-specific expression
06

Interacting drugs

Maraviroc

2 more in the full profile.

07

Biomarkers

Adeno-associated virus receptor (AAVR) expressionCoxsackievirus and adenovirus receptor (CAR) expressionLow-density lipoprotein receptor (LDLR) expressionHeparan sulfate proteoglycan (HSPG) density

Beyond the preview

Go deeper on Host cell surface receptors for viral vector entry.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell surface receptors for viral vector entry.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call